Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | DNLI |
---|---|---|
09:32 ET | 5547 | 29.33 |
09:34 ET | 864 | 29.395 |
09:41 ET | 200 | 29.405 |
09:43 ET | 2297 | 29.39 |
09:45 ET | 400 | 29.35 |
09:48 ET | 100 | 29.37 |
09:50 ET | 100 | 29.36 |
09:54 ET | 1335 | 29.22 |
09:56 ET | 1255 | 29.345 |
09:57 ET | 954 | 29.32 |
09:59 ET | 100 | 29.36 |
10:01 ET | 2718 | 29.51 |
10:03 ET | 659 | 29.42 |
10:06 ET | 300 | 29.42 |
10:08 ET | 500 | 29.31 |
10:10 ET | 236 | 29.33 |
10:12 ET | 1577 | 29.42 |
10:14 ET | 100 | 29.39 |
10:15 ET | 103 | 29.39 |
10:17 ET | 400 | 29.39 |
10:19 ET | 200 | 29.32 |
10:21 ET | 300 | 29.38 |
10:24 ET | 200 | 29.42 |
10:26 ET | 100 | 29.43 |
10:28 ET | 300 | 29.46 |
10:30 ET | 300 | 29.47 |
10:32 ET | 3640 | 29.46 |
10:33 ET | 200 | 29.44 |
10:37 ET | 1000 | 29.505 |
10:39 ET | 1917 | 29.48 |
10:42 ET | 200 | 29.51 |
10:44 ET | 2200 | 29.51 |
10:46 ET | 400 | 29.52 |
10:48 ET | 1100 | 29.52 |
10:50 ET | 409 | 29.57 |
10:51 ET | 784 | 29.5 |
10:53 ET | 300 | 29.51 |
10:55 ET | 100 | 29.52 |
10:57 ET | 200 | 29.43 |
11:00 ET | 300 | 29.49 |
11:02 ET | 1200 | 29.575 |
11:08 ET | 1238 | 29.5867 |
11:09 ET | 200 | 29.6 |
11:11 ET | 300 | 29.57 |
11:13 ET | 300 | 29.57 |
11:15 ET | 100 | 29.57 |
11:18 ET | 600 | 29.59 |
11:20 ET | 200 | 29.62 |
11:22 ET | 449 | 29.56 |
11:24 ET | 600 | 29.575 |
11:26 ET | 100 | 29.57 |
11:27 ET | 200 | 29.51 |
11:29 ET | 1501 | 29.53 |
11:31 ET | 400 | 29.53 |
11:33 ET | 1000 | 29.59 |
11:36 ET | 1500 | 29.565 |
11:38 ET | 400 | 29.54 |
11:40 ET | 200 | 29.5 |
11:42 ET | 100 | 29.49 |
11:44 ET | 900 | 29.55 |
11:45 ET | 1250 | 29.54 |
11:47 ET | 1100 | 29.55 |
11:49 ET | 302 | 29.58 |
11:51 ET | 779 | 29.53 |
11:54 ET | 100 | 29.525 |
11:56 ET | 400 | 29.54 |
11:58 ET | 100 | 29.56 |
12:02 ET | 501 | 29.525 |
12:03 ET | 600 | 29.55 |
12:05 ET | 934 | 29.53 |
12:07 ET | 488 | 29.515 |
12:12 ET | 100 | 29.52 |
12:14 ET | 200 | 29.49 |
12:16 ET | 200 | 29.43 |
12:20 ET | 100 | 29.45 |
12:21 ET | 258 | 29.4499 |
12:23 ET | 200 | 29.43 |
12:30 ET | 412 | 29.43 |
12:32 ET | 2227 | 29.425 |
12:34 ET | 700 | 29.435 |
12:36 ET | 600 | 29.43 |
12:38 ET | 200 | 29.46 |
12:39 ET | 1991 | 29.505 |
12:43 ET | 700 | 29.485 |
12:45 ET | 200 | 29.465 |
12:48 ET | 200 | 29.49 |
12:52 ET | 731 | 29.49 |
12:54 ET | 1400 | 29.505 |
12:56 ET | 800 | 29.52 |
12:57 ET | 300 | 29.52 |
12:59 ET | 600 | 29.5084 |
01:01 ET | 250 | 29.515 |
01:03 ET | 914 | 29.55 |
01:06 ET | 295 | 29.58 |
01:08 ET | 300 | 29.575 |
01:10 ET | 1180 | 29.52 |
01:12 ET | 1200 | 29.525 |
01:14 ET | 200 | 29.52 |
01:15 ET | 300 | 29.535 |
01:17 ET | 1369 | 29.6 |
01:19 ET | 159 | 29.62 |
01:21 ET | 200 | 29.64 |
01:24 ET | 250 | 29.615 |
01:26 ET | 1280 | 29.713602 |
01:30 ET | 200 | 29.74 |
01:32 ET | 700 | 29.775 |
01:33 ET | 1341 | 29.75 |
01:35 ET | 405 | 29.735 |
01:37 ET | 300 | 29.72 |
01:39 ET | 800 | 29.66 |
01:42 ET | 500 | 29.655 |
01:44 ET | 100 | 29.66 |
01:46 ET | 300 | 29.65 |
01:48 ET | 3832 | 29.73 |
01:50 ET | 400 | 29.74 |
01:51 ET | 400 | 29.7 |
01:53 ET | 100 | 29.735 |
01:55 ET | 6663 | 29.765 |
01:57 ET | 400 | 29.7555 |
02:00 ET | 1770 | 29.76 |
02:02 ET | 400 | 29.76 |
02:04 ET | 500 | 29.74 |
02:06 ET | 450 | 29.74 |
02:08 ET | 377 | 29.73 |
02:09 ET | 600 | 29.73 |
02:11 ET | 300 | 29.74 |
02:13 ET | 1200 | 29.79 |
02:15 ET | 700 | 29.78 |
02:18 ET | 300 | 29.7646 |
02:20 ET | 1500 | 29.685 |
02:26 ET | 800 | 29.58 |
02:27 ET | 200 | 29.55 |
02:29 ET | 200 | 29.525 |
02:31 ET | 600 | 29.47 |
02:33 ET | 1600 | 29.5 |
02:36 ET | 701 | 29.49 |
02:38 ET | 500 | 29.48 |
02:40 ET | 2395 | 29.505 |
02:42 ET | 1700 | 29.55 |
02:44 ET | 200 | 29.545 |
02:45 ET | 300 | 29.57 |
02:47 ET | 200 | 29.61 |
02:49 ET | 200 | 29.62 |
02:51 ET | 2100 | 29.635 |
02:54 ET | 700 | 29.615 |
02:56 ET | 200 | 29.58 |
02:58 ET | 326 | 29.6 |
03:00 ET | 500 | 29.63 |
03:02 ET | 646 | 29.615 |
03:03 ET | 200 | 29.57 |
03:05 ET | 100 | 29.58 |
03:09 ET | 1100 | 29.58 |
03:12 ET | 684 | 29.51 |
03:14 ET | 1048 | 29.5 |
03:16 ET | 900 | 29.51 |
03:18 ET | 599 | 29.455 |
03:20 ET | 650 | 29.39 |
03:21 ET | 100 | 29.39 |
03:23 ET | 700 | 29.41 |
03:25 ET | 611 | 29.4 |
03:30 ET | 300 | 29.42 |
03:32 ET | 2092 | 29.45 |
03:34 ET | 1600 | 29.42 |
03:36 ET | 791 | 29.385 |
03:38 ET | 600 | 29.39 |
03:39 ET | 214 | 29.38 |
03:41 ET | 1100 | 29.38 |
03:43 ET | 1549 | 29.34 |
03:45 ET | 600 | 29.36 |
03:48 ET | 1737 | 29.39 |
03:50 ET | 800 | 29.4 |
03:52 ET | 2877 | 29.39 |
03:54 ET | 2396 | 29.4 |
03:56 ET | 4650 | 29.39 |
03:57 ET | 4384 | 29.475 |
03:59 ET | 96257 | 29.43 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Denali Therapeutics Inc | 4.4B | -10.3x | --- |
Axsome Therapeutics Inc | 4.5B | -13.8x | --- |
CRISPR Therapeutics AG | 4.2B | -14.8x | --- |
Apellis Pharmaceuticals Inc | 4.6B | -10.8x | --- |
ADMA Biologics Inc | 4.2B | 137.9x | --- |
TG Therapeutics Inc | 3.7B | 39.7x | --- |
Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.4B |
---|---|
Revenue (TTM) | $1.3M |
Shares Outstanding | 143.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.37 |
EPS | $-2.85 |
Book Value | $7.45 |
P/E Ratio | -10.3x |
Price/Sales (TTM) | 3,476.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37,938.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.